Chelsea Clinton
Chelsea Clinton's purchase track record
Chelsea Clinton has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 3/3/2022 | CLOV | $253K | +7.2% | +5.9% | -9.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Expedia faces class-action lawsuit over hotel commission. A recent class‑action lawsuit alleges that Expedia’s 15 % commission has contributed to higher hotel prices since 2020. The claim could increase regulatory scrutiny and affect the company’s cost structure. At the same time, analysts note that Airbnb’s double‑digit growth is being weighed against rising regulatory pressure, highlighting competitive dynamics in the online travel market.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Clover Health Gains After Earning 5-Star CMS Rating. Clover Health stock rose after the company secured a 5-star rating for its PPO plan from CMS for 2027. This top score supports the company's long-term outlook and may help attract new members. The news follows a period where the stock was trading near its 52-week high, reflecting positive market sentiment.
Transaction History
| PPLI | ▲ Buy | Grant | 148 | $6K | 9/30/2026 | View on chart |
| PPLI | ▲ Buy | Grant | 135 | $6K | 6/30/2026 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 2,263 | $0 | 6/18/2026 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,609 | $0 | 6/15/2026 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 2,076 | $0 | 6/11/2026 | View on chart |
| EXPE | ▲ Buy | Option Exercise | 871 | $0 | 6/1/2026 | View on chart |
| EXPE | ▲ Buy | Option Exercise | 738 | $0 | 6/1/2026 | View on chart |
| EXPE | ▲ Buy | Option Exercise | 499 | $0 | 6/1/2026 | View on chart |
| PPLI | ▲ Buy | Grant | 156 | $6K | 3/31/2026 | View on chart |
| PPLI | ▲ Buy | Grant | 160 | $6K | 12/31/2025 | View on chart |
| PPLI | ▲ Buy | Grant | 183 | $6K | 9/30/2025 | View on chart |
| PPLI | ▲ Buy | Grant | 167 | $6K | 6/30/2025 | View on chart |
| PPLI | ▲ Buy | Grant | 1,257 | $0 | 6/23/2025 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,610 | $0 | 6/15/2025 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 2,076 | $0 | 6/11/2025 | View on chart |
| EXPE | ▲ Buy | Option Exercise | 644 | $0 | 6/1/2025 | View on chart |
| EXPE | ▲ Buy | Option Exercise | 871 | $0 | 6/1/2025 | View on chart |
| EXPE | ▲ Buy | Option Exercise | 738 | $0 | 6/1/2025 | View on chart |
| PPLI | ▲ Buy | Grant | 136 | $6K | 3/31/2025 | View on chart |
| CLOV | ▲ Buy | Grant | 60,975 | $0 | 1/6/2025 | View on chart |
| PPLI | ▲ Buy | Grant | 145 | $6K | 12/31/2024 | View on chart |
| PPLI | ▲ Buy | Grant | 116 | $6K | 9/30/2024 | View on chart |
| PPLI | ▲ Buy | Grant | 133 | $6K | 6/30/2024 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,034 | $0 | 6/23/2024 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,325 | $0 | 6/15/2024 | View on chart |
| EXPE | ▲ Buy | Option Exercise | 470 | $0 | 6/1/2024 | View on chart |
| EXPE | ▲ Buy | Option Exercise | 870 | $0 | 6/1/2024 | View on chart |
| EXPE | ▲ Buy | Option Exercise | 644 | $0 | 6/1/2024 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 549 | $0 | 5/14/2024 | View on chart |
| PPLI | ▲ Buy | Grant | 117 | $6K | 3/31/2024 | View on chart |
| CLOV | ▲ Buy | Grant | 206,185 | $200K | 1/3/2024 | View on chart |
| PPLI | ▲ Buy | Grant | 119 | $6K | 12/31/2023 | View on chart |
| PPLI | ▲ Buy | Grant | 124 | $6K | 9/30/2023 | View on chart |
| PPLI | ▲ Buy | Grant | 100 | $6K | 6/30/2023 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,347 | $0 | 6/25/2023 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,034 | $0 | 6/23/2023 | View on chart |
| EXPE | ▲ Buy | Option Exercise | 1,048 | $0 | 6/1/2023 | View on chart |
| EXPE | ▲ Buy | Option Exercise | 645 | $0 | 6/1/2023 | View on chart |
| EXPE | ▲ Buy | Option Exercise | 470 | $0 | 6/1/2023 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 549 | $0 | 5/14/2023 | View on chart |
| PPLI | ▲ Buy | Grant | 121 | $6K | 3/31/2023 | View on chart |
| CLOV | ▲ Buy | Grant | 176,991 | $0 | 1/3/2023 | View on chart |
| PPLI | ▲ Buy | Grant | 141 | $6K | 12/31/2022 | View on chart |
| PPLI | ▲ Buy | Grant | 113 | $6K | 9/30/2022 | View on chart |
| CLOV | ▲ Buy | Option Exercise | 38,392 | — | 9/22/2022 | View on chart |
| CLOV | ▲ Buy | Grant | 20,271 | $0 | 9/22/2022 | View on chart |
| PPLI | ▲ Buy | Grant | 83 | $6K | 6/30/2022 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,346 | $0 | 6/25/2022 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 1,788 | $0 | 6/12/2022 | View on chart |
| EXPE | ▲ Buy | Option Exercise | 1,049 | $0 | 6/1/2022 | View on chart |
| EXPE | ▲ Buy | Option Exercise | 725 | $0 | 6/1/2022 | View on chart |
| EXPE | ▲ Buy | Option Exercise | 472 | $0 | 6/1/2022 | View on chart |
| PPLI | ▲ Buy | Option Exercise | 548 | $0 | 5/14/2022 | View on chart |
| PPLI | ▲ Buy | Grant | 62 | $6K | 3/31/2022 | View on chart |
| CLOV | ▲ Buy | Open Market | 100,000 | $253K | 3/3/2022 | View on chart |
| PPLI | ▲ Buy | Grant | 48 | $6K | 12/31/2021 | View on chart |
| PPLI | ▲ Buy | Grant | 48 | $6K | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 11, 2026
PPLI Sets Q3 2026 Earnings Date as Sector Faces Volatility
People Incorporated announced it will hold its Q3 2026 earnings conference call on November 3rd. This update arrives while broader casino stocks, including MGM and Wynn, are experiencing record losing streaks, creating a volatile backdrop for the sector. The company's upcoming results will be a key focal point for investors watching how PPLI navigates these industry-wide pressures.
PPLI Sets Q3 2026 Earnings Date as Sector Faces Volatility. People Incorporated announced it will hold its Q3 2026 earnings conference call on November 3rd. This update arrives while broader casino stocks, including MGM and Wynn, are experiencing record losing streaks, creating a volatile backdrop for the sector. The company's upcoming results will be a key focal point for investors watching how PPLI navigates these industry-wide pressures.